Home » Teva $1 Billion Market Depends on New Test of Laquinimod
Teva $1 Billion Market Depends on New Test of Laquinimod
Teva Pharmaceutical is recruiting about 1,800 patients for a new trial of its multiple sclerosis pill in a bid to improve how the disease is treated and secure a successor to its best-selling medicine.
Businessweek
Businessweek
Upcoming Events
-
07May
-
14May
-
30May